Change in Stock | Baize Medical surged 23% with narrowed losses last year

SighingCashier · 2026-04-01T07:33:01+00:00

Bai Ze Medical (02609) narrowed its losses last year, and its stock price performed well, rising up to 22.9%, reaching a high of HKD 4.99.As of 3 p.m., the stock was at HKD 4.57, up 12.6%, with a turnover of HKD 423 million.The company announced that for the fiscal year ending last year, attributable to shareholders, the loss was RMB 12.957 million (, same below), and for 2024, the loss is projected to be RMB 13.457 million, with a loss of 1 cent per share, and no final dividend will be paid.During the period, adjusted profit was HKD 17.9 million, an increase of 43.2%. Revenue was HKD 1.112 billion, down 5.8% year-on-year.

SighingCashier

2026-04-01 07:33:01

Bai Ze Healthcare (02609) narrowed its loss last year, with the stock price strengthening and rising as much as 22.9%, reaching a high of HK$4.99.

As of 3:00 p.m., it was trading at HK$4.57, up 12.6%, with a turnover of HK$423 million.

The company announced its annual results for the year ended last year: a loss attributable to shareholders of RMB 12.957 million (RMB, same below). For FY2024, the loss was RMB 13.457 million. Loss per share was 1 cent, and no final dividend would be paid.

During the period, adjusted profit was RMB 17.90 million, up 43.2%. Revenue was RMB 1.12 billion, down 5.8% year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes